BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38474265)

  • 1. Gene Expression of
    Bark SA; Dalmolin M; Malafaia O; Roesler R; Fernandes MAC; Isolan GR
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas.
    Monteiro JM; Reis Ramos JI; Teixeira E Sousa I; Bighetti-Trevisan RL; Ribas Filho JM; Isolan GR
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of G-CSF receptor expression in medulloblastoma.
    Paul MR; Huo Y; Liu A; Lesperance J; Garancher A; Wechsler-Reya RJ; Zage PE
    Neurooncol Adv; 2020; 2(1):vdaa062. PubMed ID: 32642714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunological features of colony-stimulating factor 3 receptor in pan-cancer.
    Song L; Jiang F; Tian Y; Cao X; Zhu M; Zhang J; Wang X; Deng L
    J Gene Med; 2023 Oct; 25(10):e3508. PubMed ID: 36998239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family.
    Zage PE; Whittle SB; Shohet JM
    J Cell Biochem; 2017 Feb; 118(2):221-231. PubMed ID: 27428599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
    Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
    Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
    Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.
    Hsu DM; Agarwal S; Benham A; Coarfa C; Trahan DN; Chen Z; Stowers PN; Courtney AN; Lakoma A; Barbieri E; Metelitsa LS; Gunaratne P; Kim ES; Shohet JM
    Cancer Res; 2013 Jul; 73(13):4134-46. PubMed ID: 23687340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein and mRNA levels of YKL-40 in high-grade glioma.
    Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
    Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GCSFR/CSF3R zebrafish mutant models the persistent basal neutrophil deficiency of severe congenital neutropenia.
    Pazhakh V; Clark S; Keightley MC; Lieschke GJ
    Sci Rep; 2017 Mar; 7():44455. PubMed ID: 28281657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S; Gupta P; Shankar KB; Singh R; Siraj F
    J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
    Hutterer M; Knyazev P; Abate A; Reschke M; Maier H; Stefanova N; Knyazeva T; Barbieri V; Reindl M; Muigg A; Kostron H; Stockhammer G; Ullrich A
    Clin Cancer Res; 2008 Jan; 14(1):130-8. PubMed ID: 18172262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
    Ostrom QT; Shoaf ML; Cioffi G; Waite K; Kruchko C; Wen PY; Brat DJ; Barnholtz-Sloan JS; Iorgulescu JB
    Neuro Oncol; 2023 Apr; 25(4):799-807. PubMed ID: 35994777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.